New class of anti-cancer drug effective against kidney cancer

(UT Southwestern Medical Center) A study published in the Journal of Clinical Oncology reports initial findings with a novel drug belonging to a new class of medicines called HIF-2a inhibitors that show promise in treating metastatic kidney cancer.